Barry H. Evenchick, Partner at Pashman Stein Walder Hayden, Elected to Board of the Hereditary Disease Foundation

Evenchick.jpg

NEW YORK (July 18, 2019) – The Hereditary Disease Foundation (HDF), which funds scientific research to find treatments and cures for Huntington’s disease, announced that Barry H. Evenchick, has been elected to its Board of Directors. 

Nancy Wexler, President of HDF, said, “We are thrilled that Barry is joining our Board. His wisdom and guidance will be invaluable as we continue our work to fund innovative research that is advancing our understanding of Huntington’s disease and bringing hope to families who are affected by this devastating genetic disorder.”

Mr. Evenchick is a partner at the New Jersey-based law firm Pashman Stein Walder Hayden where his practice focuses on litigation. He is a former prosecutor, having served as chief of the appellate section of the Essex County Prosecutor’s Office and as the first chief of the appellate section of the New Jersey Division of Criminal Justice. He also served for 12 years as the municipal attorney of the Township of Livingston and for six years as a commissioner of the New Jersey State Commission of Investigation. He is an adjunct faculty member of Rutgers Law School in Newark and serves as vice-chair of the editorial board of the New Jersey Law Journal.

“I am honored and proud to be elected to the Board of the Hereditary Disease Foundation,” Mr. Evenchick said. “I look forward to working with my fellow Board members as we further our efforts to support research that is making a difference in the lives of Huntington’s disease patients and their families.”

About the Hereditary Disease Foundation

The Hereditary Disease Foundation facilitates collaborative and innovative scientific research to further the understanding of Huntington’s disease, a genetic disorder that strikes in early- to mid-adulthood, destroying brain cells and bringing on severe and progressive declines in personality, cognitive ability, and mobility. As a disease caused by a mistake on a single gene, Huntington’s disease is an ideal model for other brain disorders. Research organized by the Foundation led to the discovery of the genetic marker for Huntington’s disease in 1983. HDF organized and funded a decade-long international collaboration of over 100 scientists who discovered the gene that causes Huntington’s in 1993. This work played an important role in the development of the Human Genome Project.

For more information, visit www.hdfoundation.org.

About Pashman Stein Walder Hayden

Pashman Stein Walder Hayden is a full-service business law firm offering a wide range of corporate and personal legal services. Headquartered in Hackensack, New Jersey with offices in Monmouth County, New Jersey, and Westchester County, New York, the firm serves a diverse client base including regional Fortune 500 companies, emerging growth entities, and individuals, as well as out-of-state corporate counsel, law firms, and individuals with interests in the New York metropolitan region. Named a Regional Powerhouse in 2018 by Law360 and awarded Appellate Litigation Department of the Year (2018) by the New Jersey Law Journal and recognized by Chambers USA 2018 as one of the top law firms in New Jersey in the fields of General Commercial Litigation and White-Collar Crime & Government Investigations, Pashman Stein and its lawyers continue to be recognized for sophisticated legal skills and experience. 

For more information, visit www.pashmanstein.com.

Contact: Myrna Manners, Manners Dotson Group, mmanners@mannersdotson.com, 718-986-7255 (Mobile)

Pope Francis champions Huntington's disease, by HDF President Nancy Wexler

NW VZ.PNG

"From the moment I first visited Venezuela in 1979, which has the world’s highest prevalence of Huntington’s disease, I was moved and motivated to help and improve the lives of patients with Huntington’s disease, their families and their communities." 

Read full letter.

Anne B. Young receives 2016 Leslie Gehry Brenner Prize for Innovation in Science

Congratulations to Anne B. Young, Vice Chairman of the HDF's Board of Directors and Chair of the Scientific Advisory Board, for her pioneering research on and continued dedication to finding treatments and cures for Huntington's disease! Click here to read more.

President Obama Honors Frank Gehry With Presidential Medal of Freedom

The Hereditary Disease Foundation is thrilled to announce that HDF Board Member Frank O. Gehry has been awarded a 2016 Presidential Medal of Freedom, the nation's highest civilian honor. In a ceremony at the White House on November 22, 2016, President Obama presented the award to Frank and twenty other recipients. Obama's words were as follows:       

"Frank Gehry has never let popular acclaim defy his impulse to reverse convention. 'I was an outsider from the beginning,' he says, 'so for better or worse, I thrived on it.' The child of poor Jewish immigrants, Frank grew up in Los Angeles, and throughout his life he embraced the spirit of a city defined by an open horizon. He's spent his life rethinking shapes and mediums, seemingly the force of gravity itself; the idea of what architecture could be he decided to upend--constantly repurposing every material available, from titanium to a paper towel tube. He's inspiring our next generation through his advocacy for arts education in our schools. From the Guggenheim Bilbao to Chicago's Millennium Park--our hometown--to his home in Santa Monica which I understand caused some consternation among his neighbors, Frank's work teaches us that while buildings may be sturdy and fixed to the ground, like all great art they can lift our spirits. They can soar and broaden our horizons."

We congratulate Frank on this well-deserved and beautiful honor!